Sonoma Pharmaceuticals Logo

Press Releases

Investors
  • Overview
  • Business Development
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Oculus Innovative Sciences Announces Fiscal Fourth Quarter Financial Results and Corporate Update Release and Conference Call

May 28, 2009

Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R) Skin and Wound Gel

May 27, 2009

Oculus Innovative Sciences Reports Significant Increase in Sales of its Approved Microcyn(R) Product in Mexico as H1N1 Flu (Swine Flu) Spreads

May 4, 2009

Oculus Innovative Sciences Reports Third Quarter Product Revenue Up 19% with a $2.6 Million Reduction in Operating Expenses

Feb 12, 2009

Oculus Innovative Sciences to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

Feb 10, 2009

Oculus Innovative Sciences' Security Holders Exercise Rights or Invest in Company as Result of Recently Announced Strategic Investment by VetCure, Inc.

Feb 9, 2009

Oculus Innovative Sciences Announces Fiscal Third Quarter Financial Results and Corporate Update Release and Conference Call

Feb 9, 2009

Oculus Innovative Sciences Announces $3 Million Investment from Strategic Partner to Fund Oculus to Profitability in 12 Months

Jan 27, 2009

Oculus Innovative Sciences Reduces Additional Cash Need to $3 Million as Company Targets Breakeven Within 12 Months

Jan 26, 2009

Oculus Innovative Sciences Announces Stock Listing Remains on NASDAQ

Dec 23, 2008
RSS
    • 1...
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • ...43
    Next